STAT3 and cancer: S1PR1-STAT3 upregulation in tumor cells is critical for maintenance of persistent STAT3 signaling in cancer cells [16] and can result in premetastatic niche formation through activation of S1PR1-STAT3 and induced factors, enabling myeloid to invade and proliferate and apoptosis resistance at premetastic sites [17].